Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsNavneeteducation

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Buy UPL, Natco Pharma, JM Financial: Ashwani Gujral

      Buy UPL, Natco Pharma, JM Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying UPL, Natco Pharma and JM Financial.

    • Buy Hindalco, Natco Pharma; sell M&M Fin, UltraTech: Gujral

      Buy Hindalco, Natco Pharma; sell M&M Fin, UltraTech: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Hindalco Industries and Natco Pharma and sell M&MFinancial Services, Tata Elxsi and UltraTech Cement.

    • Buy Natco Pharma; sell ACC, CONCOR: Ashwani Gujral

      Buy Natco Pharma; sell ACC, CONCOR: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Natco Pharma and sell ACC and CONCOR.

    • Sell M&M Financial, Asian Paints; buy HPCL: Ashwani Gujral

      Sell M&M Financial, Asian Paints; buy HPCL: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can sell M&M Financial Services, Asian Paints and Centurt Ply and buy HPCL and Natco Pharma.

    • Buy NBFC stocks on dips, Voltas may test Rs 500: Ashwani Gujral

      Buy NBFC stocks on dips, Voltas may test Rs 500: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com feels that Voltas may test Rs 500.

    • Buy M&M Financial; sell Axis Bank, DHFL: Ashwani Gujral

      Buy M&M Financial; sell Axis Bank, DHFL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Mahindra and Mahindra Financial Services and suggests selling Axis Bank and Dewan Housing Finance Corporation.

    • Buy Sanghi Industries, Axis Bank, Natco Pharma: Mitesh Thacker

      Buy Sanghi Industries, Axis Bank, Natco Pharma: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can buy Sanghi Industries, Axis Bank and Natco Pharma.

    • Sell Tata Motors, Engineers India may test Rs 268: Rajat Bose

      Sell Tata Motors, Engineers India may test Rs 268: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling Tata Motors and feels that Engineers India may test Rs 268.

    • Here are a few stocks to keep an eye on August 10

      Here are a few stocks to keep an eye on August 10

      Stocks expected to gain are Sundram Fast, J&K Bank, Adani Ports, Aptech, PFC, Jubilant Life, Natco Pharma, Nitesh Estates, Globus Spirits and Emco, while stocks expected to be under pressure are Lupin, United Bank, Uco Bank, IOB, JK Tyre, Concor, Patel Integrated, Anuh Pharma, Gokaldas Exports, Kennametal, Indag Rubber, Huhtamaki PPL.

    • Buy Vijaya Bk, Syndicate Bk, Prism Cement, Natco Pharma: Gujral

      Buy Vijaya Bk, Syndicate Bk, Prism Cement, Natco Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Vijaya Bank, Syndicate Bank, Prism Cement, Delta Corp and Natco Pharma.

    • Here are a few investment ideas from Rahul Arora

      Here are a few investment ideas from Rahul Arora

      In an interview to CNBC-TV18, Rahul Arora of Nirmal Bang Institutional Equities shared his readings and outlook on specific stocks and sector.

    • Avoid Tata Motors, Tata Motors DVR; buy Jain Irrigation: Sukhani

      Avoid Tata Motors, Tata Motors DVR; buy Jain Irrigation: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can avoid Tata Motors and Tata Motors DVR on the back of Brexit referendum while one can buy Jain Irrigation Systems.

    • Buy GHCL, Unichem Laboratories, Natco Pharma: Ashwani Gujral

      Buy GHCL, Unichem Laboratories, Natco Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Gujarat Heavy Chemicals, Unichem Laboratories and Natco Pharma.

    • Buy Transformers and Rectifiers, Shreyas Shipping: Wagle

      Buy Transformers and Rectifiers, Shreyas Shipping: Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy Transformers and Rectifiers, Shreyas Shipping and Natco Pharma.

    • Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

      Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.

    • Look at Natco Pharma, says Sahil Kapoor

      Look at Natco Pharma, says Sahil Kapoor

      Sahil Kapoor of Edelweiss Broking is of the view that one may look at Natco Pharma.

    • Buy Natco Pharma, Pidilite, Cholamandalam: Sahil Kapoor

      Buy Natco Pharma, Pidilite, Cholamandalam: Sahil Kapoor

      Sahil Kapoor of Edelweiss Financial Services recommends buying Natco Pharma, Pidilite Industries and Cholamandalam Investment.

    • Hold Natco Pharma, says Sharmila Joshi

      Hold Natco Pharma, says Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may hold Natco Pharma.

    • Top buzzing midcap stocks to trade on September 1

      Top buzzing midcap stocks to trade on September 1

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have – Maruti Suzuki, Colgate, Natco Pharma, Inox Wind, United Breweries.

    • Bull's Eye: Buy Essar Oil, Castrol, UPL, sell India Cements

      Bull's Eye: Buy Essar Oil, Castrol, UPL, sell India Cements

      Avinnash Gorakssakar of Precision Investment Services advises buying Natco Pharma with a target of Rs 2525.

    • Super Six: Top chart picks for July 20

      Super Six: Top chart picks for July 20

      Sameet Chavan of Angel Broking is of the view that one may buy CESC with a target of Rs 612.

    • Go long in Natco Pharma, advises Ashish Chaturmohta

      Go long in Natco Pharma, advises Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Equity Brokers recommends going long in Natco Pharma with a target of Rs 2700-2750.

    • Exit Natco Pharma, buy Sun Pharma, Glenmark: Sukhani

      Exit Natco Pharma, buy Sun Pharma, Glenmark: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.

    • Hold Natco Pharma, advises Shahina Mukadam

      Hold Natco Pharma, advises Shahina Mukadam

      Shahina Mukadam, Market Expert is of the view that one may hold Natco Pharma.

    • Rahul Arora positive on FMCG & pharma space

      Rahul Arora positive on FMCG & pharma space

      Rahul Arora - CEO at Nirmal Bang Institutional Equities has a positive view on FMCG and pharma space and is bullish on Natco Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347